Cardioprotection: a review of current practice in global ischemia and future translational perspective

Andreas Habertheuer1, Alfred Kocher1, Günther Laufer1

  • 1Department of Cardiac Surgery, Vienna General Hospital, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria.

Insights

Protecting the heart during surgery remains crucial. Current methods for cardiac arrest have limitations, necessitating new cardioprotection strategies to improve recovery and reduce reperfusion injury in complex cardiac surgery patients.

Area of Science:

  • Cardiovascular Surgery
  • Cardioprotection
  • Ischemia Reperfusion Injury

Background:

  • Cardiac surgery necessitates protecting the heart from ischemic insult via elective cardiac arrest.
  • Current standard: high potassium cardioplegic solutions for depolarized arrest.
  • Evolving patient demographics and surgical complexity demand enhanced cardioprotection.

Purpose of the Study:

  • To address the limitations of current cardioprotection strategies in cardiac surgery.
  • To explore new avenues for myocardial protection against ischemia reperfusion injury.
  • To meet the challenges posed by complex cardiac surgeries and patient comorbidities.

Main Methods:

  • Review of current clinical practices in cardioplegia and cardioprotection.
  • Analysis of the impact of patient demographics and surgical complexity.
  • Examination of molecular mechanisms underlying ischemia reperfusion injury.

Main Results:

  • Existing cardioprotective regimens often result in impaired functional recovery due to perfusion injury.
  • Myocardial reperfusion damage significantly impacts postoperative outcomes in adult and pediatric patients.
  • A gap exists between current cardioprotection capabilities and clinical expectations.

Conclusions:

  • Enhanced understanding of molecular players in ischemia reperfusion injury is key to developing novel cardioprotective strategies.
  • New regimens are needed to overcome limitations of current methods and improve outcomes in complex cardiac surgery.
  • Advances in cardioprotection can expand the technical feasibility of cardiac procedures.

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.8K
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1.6K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
743
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
514
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
7
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
811